U.S. Food, 2025-10-15: FDA enforcement record of a Class II recall of all strengths of GenoGenix methylene blue for injection for lack of sterility assurance, initiated 30 July 2025 and classified in October 2025. It is one of the real, current methylene blue recalls, and its reason is sterility, not aniline.
Methylene Blue for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.
U.S. Food, 2025-10-15: FDA enforcement record of a Class II recall of all strengths of GenoGenix methylene blue for injection for lack of sterility assurance, initiated 30 July 2025 and classified in October 2025. It is one of the real, current methylene blue recalls, and its reason is sterility, not aniline. Record field transcription from the FDA enforcement report (machine-readable openFDA record). Recall number D-0063-2026; classification Class II; status ongoing; recall initiation 2025-07-30; report date 2025-10-15; firm GenoGenix LLC, Boca Raton FL; distribution US nationwide; reason 'Lack of Assurance of Sterility'. Note: this is not the incident described in the source. Other methylene blue recalls in the same database include Tailor Made Compounding (10 mg/mL hypotonic solution, sterility, 2022), KRS Global Biotechnology (10 mg/mL 1% injectable, labelling, 2018), Guardian Pharmacy Services (10 mg/mL, sterility, 2018) and Llorens Pharmaceutical Urin D/S tablets (out of specification assay, 2017). Confidence MEDIUM because the excerpt is a record field, not prose. HOST record is the machine-readable openFDA JSON record; there is no direct PDF, so pdf_url is blank. Study type: regulatory record.
